Facebook
Twitter
LinkedIn
Forward
Psychedelics and Psychiatric Disorders
Virtual Event!
This live virtual conference will provide up to date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Additional panel discussions and presentations will explore history, neuroscience, and additional specific relevant topics within the rapidly growing field of psychedelic medicine.
Pricing
MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before October 13, 2021): $420.00
Early Bird Registration (on or before October 22, 2021): $450.00
Regular Registration (after October 22, 2021): $475.00
Other Professionals or Trainees
Super Early Bird Registration (on or before October 13, 2021): $325.00
Early Bird Registration (on or before October 22, 2021): $375.00
Regular Registration (after October 22, 2021): $420.00
Residents: $100
Medical Students: Free
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 30, 2021. No refunds will be issued for refund requests made after October 30, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
E-Syllabus
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Co-sponsored by:
Target Audience
This program is intended for mental health practitioners including psychiatrists, psychiatric nurse practitioners, social workers and clinical psychologists.
Learning Objectives
By the end of this program, participants will be able to:
- Identify the history of psychedelic-assisted therapy within psychiatry
- List different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
- Describe the pharmacology of classical psychedelics
- Explain research using psychedelic-assisted psychotherapy for depression and anxiety disorders
- Recite specific substance use disorders that for which psychedelic-assisted therapies have shown promise
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
- Identify race-based structural biases within psychedelic research
- Describe challenges within training and education for the field of psychedelic-assisted therapy
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative medicine
- Describe some of the key challenges to conducting psychedelic research and to implicate potential treatment programs from a regulatory perspective
Psychedelic Medicine for Psychiatrists
Saturday, November 6, 2021
8:30-8:40 AM
Welcome & Introductions
Franklin King, MD; Sharmin Ghaznavi, MD, PhD; Jerrold F. Rosenbaum, MD
8:40-9:00 AM
The History of Psychedelics
Franklin King, MD
9:00-9:25 AM
The Pharmacology of Psychedelics
Franklin King, MD
9:25-9:50 AM
Psychedelics for Addictions
Brian Barnett, MD
9:50-10:15 AM
Psychedelic-Assisted Psychotherapy
Elizabeth Nielson, PhD
10:15-11:15 AM
Panel: Neuroimaging, Psychedelics, and Translational Research: How Can This Field Improve Mental Treatment Now?
Moderator: Bruce Rosen, MD, PhD
Panelists: Sharmin Ghaznavi, MD, PhD; Katrin Preller, PhD
11:15-11:25 AM
Break
11:25-12:15 PM
Panel: Regulatory Aspects of Psychedelic Research
Moderator: Jerrold F. Rosenbaum, MD
Panelists: Rick Doblin, PhD; Bertha Madras, PhD
12:15-12:45 PM
Psychedelic Therapy Training and Education: What are the Challenges in 2021?
Janis Phelps, PhD
12:45-1:30 PM
Lunch Break
1:30-2:00 PM
Challenging Structural Racism in Psychedelic Research
Monnica Williams, PhD
2:00-2:25 PM
Psychedelics for Anxiety and Mood Disorders: A Critical Review
Franklin King, MD
2:25-2:55 PM
Ketamine in Psychiatry: Pharmacology and Potential Applications
Cristina Cusin, MD
2:55-3:05 PM
Break
3:05-3:35 PM
Ketamine-Assisted Psychotherapy
Fernando Espi Forcen, MD; Maren B. Nyer, PhD
3:35-4:20 PM
The Neurobiology of Plant Medicine: What Tradition Can Teach Us About Personalized Medicine
Stephen J. Haggarty, PhD; Jacob Hooker, PhD
4:20-5:05 PM
Panel: Psychedelics and Serious Illness Care: Defining Goals in a (Re)Nascent Field
Moderator: Franklin King, MD
Panelists: Yvan Beaussant, MD; Zack Sager, MD; Roxanne Sholevar, MD
5:05-5:40 PM
Panel Question & Answer
CNP Leadership: Jerrold F. Rosenbaum, MD; Sharmin Ghaznavi, MD, PHD; Franklin King, MD;
Bruce Rosen, MD, PHD; Stephen J. Haggarty, PHD; Jacob Hooker, PHD; Jeremy N. Ruskin, MD
5:40-5:50 PM
Closing Remarks
Franklin King, MD; Sharmin Ghaznavi, MD, PhD; Jerrold F. Rosenbaum, MD
Franklin King, MD
Brian Barnett, MD
Yvan Beaussant, MD, MSc
Cristina, Cusin, MD
Rick Doblin, PhD
Fernando Espi Forcen, MD, PhD
Sharmin Ghaznavi, MD, PhD
Stephen Haggarty, PhD
Jacob Hooker, PhD
Bertha Madras, phD
Elizabeth Nielson, PhD, CASAC
Maren Nyer, PhD
Janis Phelps, PhD
Katrin Preller, PhD, PD
Bruce Rosen, MD, PhD
Jerrold Rosenbaum, MD
Jeremy Ruskin, MD
Zack Sager, MD, MA
Roxanne Sholevar, MD
Monnica Williams, PhD, ABPP
Available Credit
- 8.25 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Enduring activity for a maximum of 8.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 8.25 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 8.25 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 7.50 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 7.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90600
- 8.25 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 8.25 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 8.25 Continuing Education (CE) credits per presentation for psychologists.
Price
Planners
David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Franklin King, MD
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
Commercial Interest
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Susan Sprich, PhD (Psychologist Reviewer)
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit